The role of enhanced cutaneous IL-1β signaling in a rat tibia fracture model of complex regional pain syndrome

被引:94
|
作者
Li, Wen-wu [1 ,2 ,3 ]
Sabsovich, Ilya [1 ,2 ,3 ]
Guo, Tian-Zhi [2 ]
Zhao, Rong [2 ]
Kingery, Wade S. [2 ,4 ]
Clark, J. David [1 ,3 ]
机构
[1] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, Palo Alto, CA 94304 USA
[2] Vet Affairs Palo Alto Hlth Care Syst, Phys Med & Rehabil Serv, Palo Alto, CA 94304 USA
[3] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Orthoped Surg, Stanford, CA 94305 USA
关键词
Cytokines; Fracture; Complex regional pain syndrome; Nerve growth factor; TUMOR-NECROSIS-FACTOR; NERVE GROWTH-FACTOR; SYNDROME TYPE-I; INTERLEUKIN-1 RECEPTOR ANTAGONIST; BONE CANCER PAIN; PROINFLAMMATORY CYTOKINES; INFLAMMATORY HYPERALGESIA; SYNDROME TYPE-1; NEUROPATHIC PAIN; FACTOR-ALPHA;
D O I
10.1016/j.pain.2009.04.033
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Tibia fracture in rats initiates a syndrome resembling the complex regional pain syndrome type I. Accumulating evidence indicates that IL-1 beta is involved ill the modulation of nociceptive information and it acts as an intermediate inflammatory mediator via up-regulation of NGF. We hypothesized that I signaling might mediate the development of the CRPS-like changes after tibial fracture, either directly or by stimulating NGF expression. Rats underwent distal tibia fracture and casting for 4 weeks and were chronically treated with an IL-1 receptor antagonist (IL-1ra). Nociceptive testing and assessment of edema and hindpaw warmth were performed at baseline and after cast removal. Bone microarchitecture was evaluated by micro-computed tomography. Confocal immunofluorescence and in situ hybridization techniques were used to evaluate changes in the cutaneous expression of IL-1 beta at 4 weeks post-fracture. The nociceptive and vascular effects of intraplantar IL-1 beta injections were evaluated in intact rats at different time points after injection. We found that: ( I) IL-1ra reduced fracture-induced nociceptive sensitization, but did not decrease hindpaw edema or warmth, (2) fracture chronically up-regulated IL-1 beta mRNA and protein expression in hindpaw skin keratinocytes, (3) IL-1 beta intraplantar injection induced mechanical allodynia in a dose-dependent manner and stimulated keratinocyte NGF expression in the hindpaw skin, and (4) intraplantar injection of NGF-induced nociceptive sensitization. Collectively, these results indicate that Cutaneous IL-1 beta signaling can contribute to chronic regional nociceptive sensitization after fracture, possibly by stimulating NGF over-expression in keratinocytes. Our data also highlight the importance of the keratinocyte as the primary Source of post-traumatic IL-1 beta over-expression. Published by Elsevier B.V. on behalf of International Association for the Study of Pain.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 46 条
  • [1] Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome
    Wei, Tzuping
    Sabsovich, Ilya
    Guo, Tian-Zhi
    Shi, Xiaoyou
    Zhao, Rong
    Li, Wenwu
    Geis, Christian
    Sommer, Claudia
    Kingery, Wade S.
    Clark, David J.
    EUROPEAN JOURNAL OF PAIN, 2009, 13 (03) : 253 - 262
  • [2] Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome
    Guo, Tian-Zhi
    Wei, Tzuping
    Shi, Xiaoyou
    Li, Wen-Wu
    Hou, Saiyun
    Wang, Liping
    Tsujikawa, Kazutake
    Rice, Kenner C.
    Cheng, Kejun
    Clark, David J.
    Kingery, Wade S.
    MOLECULAR PAIN, 2012, 8
  • [3] The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome
    Li, Wen-Wu
    Guo, Tian-Zhi
    Liang, Deyong
    Shi, Xiaoyou
    Wei, Tzuping
    Kingery, Wade S.
    Clark, J. David
    PAIN, 2009, 147 (1-3) : 277 - 286
  • [4] Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I
    Sabsovich, Ilya
    Wei, Tzuping
    Guo, Tian-Zhi
    Zhao, Rong
    Shi, Xiaoyou
    Li, Xiangqi
    Yeomans, David C.
    Klyukinov, Mikhail
    Kingery, Wade S.
    Clark, J. David
    PAIN, 2008, 138 (01) : 47 - 60
  • [5] Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I
    Wei, Tzuping
    Li, Wen-wu
    Guo, Tian-Zhi
    Zhao, Rong
    Wang, Liping
    Clark, David J.
    Oaklander, Anne Louise
    Schmelz, Martin
    Kingery, Wade S.
    PAIN, 2009, 144 (03) : 278 - 286
  • [6] Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome
    Li, Wen-Wu
    Guo, Tian-Zhi
    Shi, Xiaoyou
    Birklein, Frank
    Schlereth, Tanja
    Kingery, Wade S.
    Clark, J. David
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [7] Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome
    Wen-Wu Li
    Tian-Zhi Guo
    Xiaoyou Shi
    Frank Birklein
    Tanja Schlereth
    Wade S. Kingery
    J. David Clark
    Journal of Neuroinflammation, 15
  • [8] Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome
    Wang, Liping
    Guo, Tian-Zhi
    Wei, Tzuping
    Li, Wen-Wu
    Shi, Xiaoyou
    Clark, J. David
    Kingery, Wade S.
    ANESTHESIA AND ANALGESIA, 2016, 123 (04) : 1033 - 1045
  • [9] TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I
    Sabsovich, Ilya
    Guo, Tian-Zhi
    Wei, Tzuping
    Zhao, Rong
    Li, Xiangqi
    Clark, David J.
    Geis, Christian
    Sommer, Claudia
    Kingery, Wade S.
    PAIN, 2008, 137 (03) : 507 - 519
  • [10] Oxidative Stress Contributes to Fracture/Cast-Induced Inflammation and Pain in a Rat Model of Complex Regional Pain Syndrome
    Guo, Tian-Zhi
    Wei, Tzuping
    Huang, Ting-Ting
    Kingery, Wade S.
    Clark, John David
    JOURNAL OF PAIN, 2018, 19 (10) : 1147 - 1156